a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with NTLA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To NRIX | 1D Price Change % | ||
---|---|---|---|---|
NRIX | 100% | -1.35% | ||
NTLA - NRIX | 48% Loosely correlated | -3.65% | ||
BEAM - NRIX | 46% Loosely correlated | -8.55% | ||
DAWN - NRIX | 45% Loosely correlated | -2.46% | ||
ALLO - NRIX | 44% Loosely correlated | -4.56% | ||
EDIT - NRIX | 44% Loosely correlated | -6.68% | ||
More |
Ticker / NAME | Correlation To NRIX | 1D Price Change % |
---|---|---|
NRIX | 100% | -1.35% |
small molecule therapies theme (2 stocks) | 96% Closely correlated | +1.07% |
biopharmaceutical theme (11 stocks) | 66% Closely correlated | +0.06% |
cancer theme (87 stocks) | 54% Loosely correlated | +0.89% |
therapeutics theme (57 stocks) | 46% Loosely correlated | +20.54% |